SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CERN -- a player in the health-care infor. industry
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
2 1 0 CERN
Emcee:  pcyhuang Type:  Unmoderated
We recommend the purchase of Cerner Corporation
(CERN @$17). CERN designs, develops, markets,
installs and supports information systems and
content solutions for health organizations and
consumers. For the fiscal year ended 12/28/02,
revenues increased 39% to $751.9 million.
Net income before accounting change totaled $48.8
million, vs. a loss of $42.4 million. We estimate
CERN will earn $1.20 per share on revenue of $832
million this year and $1.60 per share next year.
Projecting an average per share earnings growth
rate of 25%, we estimate CERN's current PEG
ratio to be .7x, substantially below those of its
peers'. In recent months, CERN has reported 9 net
insiders' buyings.

moneycentral.msn.com.
Click here for detailed company report.

pcyhuang
huangcapital.com
Huang's Mechanical Hedge Investing
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):